Highly sensitive ELISA for soluble Fas in serum: Increased soluble Fas in the elderly

Clinical Chemistry

Volumn 42, Issue 12, 1996, Pages 1911-1914

  Seishima, Mitsuru ^a   Takemura, Masao ^a   Saito, Kuniaki ^a   Sano, Hirotake ^a   Minatoguchi, Shinya ^a   Fujiwara, Hisayoshi ^a   Hachiya, Takahisa ^b   Noma, Akio ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Medical & Biological Laboratories Co Ltd   (Japan)

Author keywords

aging; apoptosis; transmembrane protein; tumor necrosis factor receptor

Indexed keywords

CYTOKINE RECEPTOR; FAS ANTIGEN; MEMBRANE PROTEIN; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; AGING; ANALYTIC METHOD; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; APOPTOSIS; ARTICLE; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SERUM; SEX DIFFERENCE;

EID: 0029852934     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.12.1911     Document Type: Article

References (13)

1. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 1994;76:777-9.
2. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
3. Watanabe FR, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148:1274-9.
4. Suda T, Nagata S. Purification and characterization of the Fasligand that induces apoptosis. J Exp Med 1994;179:873-9.
5. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-43.
6. Trauth BC, Klas C, Peters AMJ, Matzku S, Moeller P, Falk W, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301-4.
7. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994;263:1759-62.
8. Schall TJ, Lewis M, Koller K, Lee A, Rice GC, Wong GHW, et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990;61:361-70.
9. Goodwin RG, Friend D, Ziegler SF, Jerzy R, Falk BA, Gimpel S, et al. Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 1990;60:941-51.
10. Mountz JD, Pierson MC, Zhou T, Cheng J, Elkon KB, Hasunuma T, et al. sFas expression in patients with autoimmune disease. Arthritis Rheum 1995;38:S174.
11. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989;169:1747-56.
12. Zhou T, Edwards CK III, Mountz JD. Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice. J Exp Med 1995; 182:129-37.
13. Tanaka T, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 1995;14:1129-35.